Clinical Trials at Memorial Sloan Kettering Cancer Center (All Protocol Activites)
As of September 2026, 38 paid clinical trials are recruiting at Memorial Sloan Kettering Cancer Center (All Protocol Activites), located at 1275 YORK AVE, MEMORIAL 7, NEW YORK, NY 10065-6007, phone (212) 639-2000 in New York, New York. Active studies at this site cover conditions such as Breast Cancer, Prostate Cancer and Multiple Myeloma. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in New York
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
39 clinical trials at Memorial Sloan Kettering Cancer Center (All Protocol Activites)
·Clear filters·A Study of ELI-002 7P, With or Without Tislelizumab, in People With Pancreatic Cancer
A Study of Magnetic Resonance Imaging of the Pancreas for Cancer Screening
Comparing Two Different Boost Approaches in Radiation Therapy for People With Prostate Cancer
HERizon-Breast: A ctDNA-Guided Adaptive Study of Sequential Anti-HER2 Therapies and CNS Prophylaxis to Induce Long-Term Remission
A Study of Cardiac Magnetic Resonance Imaging (CMR) for Evaluating Catheter-Associated Right Atrial Clot in People With Cancer
A Study Comparing Two Optical Coherence Tomography Devices in People With Ocular Tumors
A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma
A Study of Isoquercetin in People With Ovarian Cancer
A Study of Neuropathy Caused by Enfortumab Vedotin in People With Urothelial Carcinoma
Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism
Operator Radiation Exposure During Image-Guided Robotic-Assisted Bronchoscopy: A Multicenter Prospective Cohort Study
A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy
A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung Cancer
A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander Placement
A Study of BMS986365 in Combination With Degarelix in People With Prostate Cancer
Factors Associated With Breast Cancer Risks and Outcomes
Hyperpolarized C Pyruvate Magnetic Resonance Imaging, and Blood-Based Biomarkers for Early Detection of Pancreatic Adenocarcinoma in Patients With Intraductal Papillary Mucinous Neoplasms
A Study of Changes in Heart Function and Blood Flow in People Receiving Anesthesia
MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial
Normative Ranges of Lingual Strength and Endurance and the Impact of the IOPI Lingual Strength Trainer on Quantitative Functional Outcomes and Patient-Reported Outcomes After Partial Glossectomy or Hemiglossectomy for Oral Tongue Cancer, An Unblinded: Randomized Pilot Study
A Study of Surgical Techniques During Cystectomy
A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC)
A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia
A Study of Hospital-at-Home for People Receiving Tarlatamab
A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer
A Study of Surgery and Radiotherapy in People With Breast Cancer
The Efficacy of Conventional Screening Versus mHealth Screening in Early Detection of Oral Potentially Malignant Disorders and Oral Cancer Amongst the Rural Population of Varanasi: A Prospective and Blinded Study
A Study of Pembrolizumab and Cryoablation in People With Breast Cancer
Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With Sarcoma
A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors
A Study of the Use of 3D Technology to Guide Head and Neck Surgery
A Study of 2141-V11 in Combination With Standard Treatments in People With Prostate Cancer
A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)
A Study of Cemiplimab and Fianlimab in People With Clear Cell Renal Cell Carcinoma
A Study of Breast Cancer Risk Factors and Outcomes of People in Florida
A Study Collecting Health Information to Understand and Prevent Gastric Cancer
An Acupuncture Study for Cancer Survivors With Joint Pain
A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma
Common conditions studied in New York
- Breast Cancer (92 active studies)
- Prostate Cancer (74 active studies)
- Multiple Myeloma (44 active studies)
- Colorectal Cancer (42 active studies)
- Ovarian Cancer (41 active studies)
- Endometrial Cancer (37 active studies)
Leading research sponsors in New York
- Memorial Sloan Kettering Cancer Center
- NYU Langone Health
- Columbia University
- Icahn School of Medicine at Mount Sinai
- Weill Medical College of Cornell University
Frequently asked questions
How many paid clinical trials are currently recruiting in New York?
There are approximately 3,375 recruiting clinical trials in New York, New York listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in New York pay participants?
Most recruiting trials in New York compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in New York?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in New York?
The most common conditions under active study in New York include Breast Cancer (92), Prostate Cancer (74), Multiple Myeloma (44), Colorectal Cancer (42), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in New York?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in New York on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in New York?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in New York?
Recruiting research sites in New York include Memorial Sloan Kettering Cancer Center, NYU Langone Health, Icahn School of Medicine at Mount Sinai, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in New York right now?
The largest active categories in New York are Cancer & tumors (1,129), Neurology & pain (198), Cardiovascular (195). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Memorial Sloan Kettering Cancer Center (All Protocol Activites)?
Memorial Sloan Kettering Cancer Center (All Protocol Activites) is located at 1275 YORK AVE, MEMORIAL 7, NEW YORK, NY 10065-6007. Use the Google Maps link in the intro above to get directions.
How do I contact Memorial Sloan Kettering Cancer Center (All Protocol Activites)?
You can reach Memorial Sloan Kettering Cancer Center (All Protocol Activites) by phone at (212) 639-2000. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.